top of page
With an engineering background, Guillaume Rousseau plunged into the field of bioproduction by doing his PhD in Pr. Douay’s lab to develop an industrial production process of red blood cells from stem cells. His work led to the founding of Erypharm in 2016 to pursue the project with more ambitious means. Since then, he has been leading Erypharm’s R&D department, setting up a complementary team of biologists and process engineers to develop and optimize the production process with a transdisciplinary approach and turn this long-standing dream into a clinical reality.
bottom of page